Results 81 to 90 of about 607 (121)
Contraceptive efficacy and safety of DMPA-SC [PDF]
openaire +1 more source
This formative assessment, conducted in 2023, was an exploratory qualitative inquiry designed to understand potential user, service provider and stakeholder perspectives on how to offer, introduce and support the use of DMPA-SC self-injection in ways that meet the needs and interests of women in Punjab, Pakistan.
Qayyum, Kanwal +7 more
openaire +1 more source
Background Although self-injectable subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has demonstrated promise, there are significant barriers in promoting initiation and continued use in low-resource settings.
Grace W. Kimemia +10 more
doaj +1 more source
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 27, Issue S6, November 2024.
wiley +1 more source
Education as an enabler, not a requirement: ensuring access to self-care options for all
Caitlin Corneliess +5 more
doaj +1 more source
Following the introduction of the second injectable contraceptive DMPA-SC Sayana Press in 2015, as the country does not yet have data to quantify the annual needs of this new product, it was decided to test 2/3 Dépo-provera and 1/3 Sayana Press. This proportion was too ambitious for the beginning and spawned an overstock for the Sayana ...
openaire +1 more source
Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study. [PDF]
Mwembo A +6 more
europepmc +1 more source
An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa. [PDF]
Bertrand JT +5 more
europepmc +1 more source
Barriers and Facilitators to Expanding User-Administered Injectable Contraceptives in the United States. [PDF]
Clark C, Cheng AL, Creason L, Karlin J.
europepmc +1 more source

